GSK-3326595

Product Name: GSK-3326595
CAS No.: 1616392-22-3
Chemical Name: GSK-3326595
Synonyms: GSK3326595;6-[(1-acetylpiperidin-4-yl)amino]-N-[(2S)-2-hydroxy-3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]pyrimidine-4-carboxamide;EPZ-015938;GSK-3326595,EPZ-015938;EPZ-015938 (GSK3326595);EPZ015938(pemrametostat);GSK3326595, 10 mM in DMSO;Pemrametostat (GSK3326595);EPZ015938; EPZ 015938; EPZ-015938;Pemrametostat (GSK3326595) ，S8664
CBNumber: CB03121890
Molecular Formula: C24H32N6O3
Formula Weight: 452.55
MOL File: 1616392-22-3.mol

More

Less

GSK-3326595 Property

Boiling point:: 760.3±60.0 °C(Predicted)
Density: 1.275±0.06 g/cm3(Predicted)
storage temp.: under inert gas (nitrogen or Argon) at 2–8 °C
solubility: Soluble in DMSO (up to 20 mg/ml).
pka: 12.44±0.46(Predicted)
form: solid
color: Off-white
Stability:: Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month.
InChIKey: JLCCNYVTIWRPIZ-NRFANRHFSA-N
SMILES: C1=NC(NC2CCN(C(C)=O)CC2)=CC(C(NC[C@H](O)CN2CCC3=C(C2)C=CC=C3)=O)=N1

More

Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Warning

Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P321Specific treatment (see … on this label).

P330Rinse mouth.

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P337+P313IF eye irritation persists: Get medical advice/attention.

P403+P233Store in a well-ventilated place. Keep container tightly closed.

P405Store locked up.

P501Dispose of contents/container to..…

More

Less

N-Bromosuccinimide Price

Cayman Chemical

Product number: 27305
Product name: GSK3326595
Packaging: 5mg
Price: $116
Updated: 2024/03/01

Cayman Chemical

Product number: 27305
Product name: GSK3326595
Packaging: 25mg
Price: $343
Updated: 2024/03/01

Cayman Chemical

Product number: 27305
Product name: GSK3326595
Packaging: 1mg
Price: $32
Updated: 2024/03/01

Cayman Chemical

Product number: 27305
Product name: GSK3326595
Packaging: 10mg
Price: $199
Updated: 2024/03/01

ChemScene

Product number: CS-6451
Product name: GSK3326595
Purity: 99.55%
Packaging: 5mg
Price: $50
Updated: 2021/12/16

More

Less

GSK-3326595 Chemical Properties,Usage,Production

Description

GSK3326595 (1616395-22-3) is a potent (IC50?= 6.2nM), selective (>4000-fold over 20 other methyltransferases), SAM uncompetitive, peptide competitive inhibitor of PRMT5.1?PRMT5 inhibition activated the p53 pathway?via?induction of alternative splicing of MDM4 leading to a potent anti-proliferative response both?in vitro?and?in vivo. Combination therapy with palbociclib (CDK4/6 inhibitor, Focus Cat.# 10-4760) and GSK3326595 lead to increased efficacy of palbociclib in treating native and resistant models of melanoma via regulation of the PRMT5-MDM4 axis.2?Currently in clinical trials.3

Uses

GSK-3326595 is a protein arginine methyltransferase 5(PRMT5) inhibitor under clinical trial.

in vivo

GSK3326595 (5 mg/kg, Intraperitoneal injection, three times a week for 9?weeks) increased hepatic triglyceride levels without affecting atherosclerosis in LDL receptor knockout mice^[3]. GSK3326595 (25-50 mg/kg, Oral, once a day for 2?weeks) enhances the efficacy of anti-programed cell death protein 1 (PD-1) immune checkpoint therapy (ICT) in hepatocellular carcinoma (HCC) in myelocytomatosis transgene turned on (MYC-ON) mice^[5].

Animal Model:	LDL receptor knockout mice^[3]
Dosage:	5 mg/kg
Administration:	Intraperitoneal injection (i.p.)
Result:	Did not alter atherosclerosis susceptibility. Increased hepatic triglyceride levels without changing the hyperlipidemia extent. Activated genes involved in fatty acid acquisition.

Animal Model:	myelocytomatosis transgene turned on mice^[5]
Dosage:	25 mg/kg, 50 mg/kg
Administration:	Oral
Result:	Significantly suppressed tumor growth at 50 mg/kg. Showed better therapeutic efficacy at 25 mg/kg.

IC 50

PRMT5; CDK4; CDK6

References

[1] SARAH V GERHART. Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing.[J]. Scientific Reports, 2018: 9711. DOI:10.1038/s41598-018-28002-y
[2] SHATHA ABUHAMMAD. Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2019, 116 1: 17990-18000. DOI:10.1073/pnas.1901323116

GSK-3326595 Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

GSK-3326595 Suppliers

China 102 India 1 United States 7 USA 1 Global 111

Dezhou LonWel Pharmaceutical Technology Co., Ltd.

Tel: 13761310616
Fax: QQ: 39324283
Email: 39324283@qq.com
Country: China
ProdList: 1637
Advantage: 58

Deyang Sino Biotech. Co., LTD

Tel: +86-19182167371 +86-19182167371;
Email: service@synlord.com
Country: China
ProdList: 110
Advantage: 58

Beijing HwrkChemical Technology Co., Ltd

Tel: 18515581800 18501085097
Fax: 010-89508210
Email: sales.bj@hwrkchemical.com
Country: China
ProdList: 9400
Advantage: 55

Shanghai Topbiochem Technology Co., Ltd

Tel: 021-58170097
Email: info@topbiochem.com
Country: China
ProdList: 9510
Advantage: 58

ShangHai Caerulum Pharma Discovery Co., Ltd.

Tel: 18149758185
Email: sales-cpd@caerulumpharma.com
Country: China
ProdList: 3506
Advantage: 58

AdooQ Bioscience CHINA

Tel: 025-58849295 18951903616;
Fax: 025-68650336
Email: info@adooq.cn
Country: China
ProdList: 2990
Advantage: 60

Shanghai YuanQi Biotechnology Co., Ltd.

Tel: +86-2332782371 +86-18120098618
Email: sales@adobechem.com
Country: China
ProdList: 1250
Advantage: 50

Shanghai Lollane Biological Technology Co.,Ltd.

Tel: 021-52996696，15000506266 15000506266
Fax: +86-21-52996696
Country: China
ProdList: 4757
Advantage: 55

Shanghaizehan biopharma technology co., Ltd.

Tel: 021-61350663 13052117465
Fax: 021-61350662
Email: sales@zehanbiopharma.com
Country: China
ProdList: 984
Advantage: 55

Shanghai Biolang biotechnology Co.,Ltd

Tel: 17764003753
Fax: 13669031409
Email: 2326587775@qq.com
Country: China
ProdList: 188
Advantage: 55

1616392-22-3, GSK-3326595Related Search:

Diethylene glycol monomethyl ether GSK583 GSK461364 GSK547 GSK-467 GSK481 4-Chloro-N-[2-[[5-(trifluoromethyl)-2-pyridinyl]sulfonyl]ethyl]benzamide GSK-2256098 GSK369796 GSK2982772 MethanesulfonaMide, N-[5-[4-[5-[[(2R,6S)-2,6-diMethyl-4-Morpholinyl]Methyl]-2-oxazolyl]-1H-indazol-6-yl]-2-Methoxy-3-pyridinyl]-, rel- GSK2636771 GSK-2881078 GSK-2018682 GSK2126458 GSK484 N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide RET Kinase inhibitor 1

6-[(1-acetylpiperidin-4-yl)amino]-N-[(2S)-2-hydroxy-3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]pyrimidine-4-carboxamide

GSK3326595

EPZ-015938

4-Pyrimidinecarboxamide, 6-[(1-acetyl-4-piperidinyl)amino]-N-[(2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-

GSK-3326595,EPZ-015938

EPZ-015938 (GSK3326595)

4-tetrahydroisoquinolin-2-yl)propyl]pyrimidine-4-carboxamid

6-[(1-acetylpiperidin-4-yl)amino]-N-[(2S)-2-hydroxy-3-(1

EPZ015938; 6-[(1-ACETYLPIPERIDIN-4-YL)AMINO]-N-[(2S)-2-HYDROXY-3-(1;2;3;4-TETRAHYDROISOQUINOLIN-2-YL)PROPYL]PYRIMIDINE-4-CARBOXAMID

EPZ015938; EPZ 015938; EPZ-015938

EPZ015938(pemrametostat)

6-[(1-acetyl-4-piperidyl)amino]-N-[(2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxy-propyl]pyrimidine-4-carboxamide

Pemrametostat, GSK3326595, EPZ015938

Pemrametostat (GSK3326595)

GSK3326595, 10 mM in DMSO

Pemrametostat (GSK3326595) ，S8664

1616392-22-3

API